Why the TGA should reschedule MDMA and psilocybin for the treatment of mental illness
(Version anglaise seulement)
par Sarah-Catherine Rodan, PhD candidate, University of Sydney
Samuel Banister, Team Leader in Medicinal Chemistry, University of Sydney
The TGA is considering a proposal to reclassify psilocybin and MDMA from their current status as prohibited substances. This would allow psychiatrists to use these drugs to treat mental illness.
Lire l'article complet
© La Conversation
-
jeudi 20 mai 2021
